These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 21810018

  • 1. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
    Matsuyama K, Ogata N, Matsuoka M, Wada M, Nishimura T, Takahashi K.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):379-83. PubMed ID: 21810018
    [Abstract] [Full Text] [Related]

  • 2. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
    Nonobe NI, Kachi S, Kondo M, Takai Y, Takemoto K, Nakayama A, Hayakawa M, Terasaki H.
    Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M.
    Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
    [Abstract] [Full Text] [Related]

  • 4. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T.
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes.
    Miyake T, Sawada O, Kakinoki M, Sawada T, Kawamura H, Ogasawara K, Ohji M.
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1606-8. PubMed ID: 19875666
    [Abstract] [Full Text] [Related]

  • 6. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys.
    Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M.
    Invest Ophthalmol Vis Sci; 2012 Aug 24; 53(9):5877-80. PubMed ID: 22836776
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab.
    Sawada O, Kawamura H, Kakinoki M, Ohji M.
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct 24; 246(10):1379-81. PubMed ID: 18581130
    [Abstract] [Full Text] [Related]

  • 8. Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans.
    Meyer CH, Krohne TU, Holz FG.
    Acta Ophthalmol; 2012 Feb 24; 90(1):68-70. PubMed ID: 20163369
    [Abstract] [Full Text] [Related]

  • 9. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J, Lu Q, Tao Y, Jiang YR.
    Retina; 2011 Jan 24; 31(1):161-8. PubMed ID: 20890241
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab.
    Matsuyama K, Ogata N, Matsuoka M, Wada M, Takahashi K, Nishimura T.
    Br J Ophthalmol; 2010 Sep 24; 94(9):1215-8. PubMed ID: 20538658
    [Abstract] [Full Text] [Related]

  • 11. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
    Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, Zhang X.
    Invest Ophthalmol Vis Sci; 2013 Jun 04; 54(6):3874-9. PubMed ID: 23674760
    [Abstract] [Full Text] [Related]

  • 12. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
    Roh MI, Kim HS, Song JH, Lim JB, Kwon OW.
    Ophthalmology; 2009 Jan 04; 116(1):80-6. PubMed ID: 19118699
    [Abstract] [Full Text] [Related]

  • 13. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab.
    Matsuyama K, Ogata N, Jo N, Shima C, Matsuoka M, Matsumura M.
    Jpn J Ophthalmol; 2009 May 04; 53(3):243-8. PubMed ID: 19484443
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
    Ma Y, Zhang Y, Zhao T, Jiang YR.
    Am J Ophthalmol; 2012 Feb 04; 153(2):307-313.e2. PubMed ID: 21982107
    [Abstract] [Full Text] [Related]

  • 15. Dose of intravitreal bevacizumab (Avastin) used as preoperative adjunct therapy for proliferative diabetic retinopathy.
    Hattori T, Shimada H, Nakashizuka H, Mizutani Y, Mori R, Yuzawa M.
    Retina; 2010 May 04; 30(5):761-4. PubMed ID: 20453802
    [Abstract] [Full Text] [Related]

  • 16. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
    Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A, Kitaoka T.
    Am J Ophthalmol; 2012 May 04; 153(5):896-902.e1. PubMed ID: 22265145
    [Abstract] [Full Text] [Related]

  • 17. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
    dell'Omo R, Cassetta M, dell'Omo E, di Salvatore A, Hughes JM, Aceto F, Porcellini A, Costagliola C.
    Am J Ophthalmol; 2012 Jan 04; 153(1):155-61.e2. PubMed ID: 21861975
    [Abstract] [Full Text] [Related]

  • 18. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM, Lai TY, Chan KP, Li H, Liu DT, Lam DS, Pang CP.
    Retina; 2008 Oct 04; 28(9):1308-13. PubMed ID: 18728623
    [Abstract] [Full Text] [Related]

  • 19. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.
    Krohne TU, Eter N, Holz FG, Meyer CH.
    Am J Ophthalmol; 2008 Oct 04; 146(4):508-12. PubMed ID: 18635152
    [Abstract] [Full Text] [Related]

  • 20. Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.
    Ushida H, Kachi S, Asami T, Ishikawa K, Kondo M, Terasaki H.
    Ophthalmic Res; 2013 Oct 04; 49(1):30-6. PubMed ID: 23038607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.